{"name":"Kumquat Biosciences Inc.","slug":"kumquat-biosciences-inc","ticker":"","exchange":"","domain":"kumquat.com","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"Pharma / Biotech","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"KQB198","genericName":"KQB198","slug":"kqb198","indication":"Other","status":"phase_2"}]}],"pipeline":[{"name":"KQB198","genericName":"KQB198","slug":"kqb198","phase":"phase_2","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.com/rss/articles/CBMid0FVX3lxTE16Mk1LejU4ODdUWW02VDU3bFc0Qzh2MUo3b2NMcER6WGRvTUVRZ0RCdG55TkVna3M4RXQ0a0RYbkdpR0pqUVRVZkhrRG8yaE53cTZRYjVxeHdKVE92N3lBMDU5SjN0cWlTQlpUNTU4bkdLakliczFZ?oc=5","date":"2025-08-19","type":"deal","source":"San Diego Business Journal","summary":"Kumquat Bio Inks $1.3B Bayer Deal - San Diego Business Journal","headline":"Kumquat Bio Inks $1.3B Bayer Deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi0AFBVV95cUxQNGZlYVlsOFRCV3lVS0dPWjdFbE9sazZiTVY2bHluS2xWa2pXT1hjVkJjOHNIMzlhUURoVHh5b1EzS2dXQy1NOUFMS3Rlc0c0WFVPTEM1SDljeE0yb0lidUNIRjZzczN0YlJJQXlvYXlKUEZ4RnBmX2RSODZOYnR4YjR5M01uZ1dQaUlHNGIzQVNrNmlpbzVXblBRMEpDeWh2cldXTlp4TU03SFBNQlZmRjRyRjVIcllVZEVuSXFUUVk2UHl3d3o3bmhYcmY4WEVV0gHWAUFVX3lxTE5MVWU4OENTcUNkSUgyVDNzeXJIU3E1WmZwYkxqVFp4TFBSY29DTDlSR0JxSHl2blBoLURkcDVPTXYzcW9wZ0c0WWNrZGVsN3A5T0xBME5OZGc0TkZ3LTNvQ1RZWkdqWVR0N0ZGUkJ2QWFuMnNpVFgwek5wZjhNb0RtRTVOSUN0VWxfM1BQVWcza2hQWEk0UDNnbU11WVNtVnF0ZEhwSXg1SW9sMnBRbmY2dTNRT0FiOWVNbE45eUJGek82amREU2tvaVdXdjdmWjNSYUdQQnc?oc=5","date":"2025-08-15","type":"pipeline","source":"Medical Dialogues","summary":"Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitor - Medical Dialogues","headline":"Bayer, Kumquat Biosciences ink pact to develop, commercialize KRAS G12D inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiwgFBVV95cUxPaEt1cFVBSW5NckljY1ZqZkdJb2xKa1hKdzJVaDVicUNoUkFOUUtWTzdhMlFSM0xlODM4RGlEWHlLLWxjSGJ4QktrdWM0ZjJ5dnRMRVBlQ2JqYWJhRmNTNFBrZ2ZTd0F2LU53Nk9rT3ZQVmRaaURvdzcwNlRwZ21aX1ZrNWtjRDJBVXU3S3l4UXcyTHRwUlVuM1hLR0RIMEZhdGVRUFFFQWJMT3ZYWWUxbDVJUnotY09hUktVdlRYWFpIZw?oc=5","date":"2025-08-13","type":"deal","source":"Contract Pharma","summary":"Bayer, Kumquat Biosciences Partner to Develop & Commercialize KRAS G12D Inhibitor - Contract Pharma","headline":"Bayer, Kumquat Biosciences Partner to Develop & Commercialize KRAS G12D Inhibitor","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMi7AFBVV95cUxNWlB0aFdBUlVFeXdQajZvUUVBZktrMGpKTUNfR0JIZE9hel91NlpzY2dzTUpDbWlzT1lUNlZIcWdnZ1RncjQyV190bHFoRmlOUmRKdjBuZ0VLUVRtR3FvS0Zsa1dZZW96WmhHMURFSVRBN0c0M3pCOGNMbXU5bjNTZWJVb3hQMWJ0R0lCTjdCbFZpM1Zvdld6U2NFc0g0OUVOS3ZVQzRCb0V0U2Fib2FNVU9yX2RXR3BQZFY3THlteTJPVU5SLVhlckxBaVFwd0hGaVp2X0liemZlXzdGYU9OMHYyc09HVFRWeXgxaw?oc=5","date":"2025-08-12","type":"deal","source":"PR Newswire","summary":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology - PR Newswire","headline":"Bayer and Kumquat Biosciences enter global exclusive license and collaboration in precision oncology","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMitAFBVV95cUxQVExBRXhJSXlYYlExYmsxUGlPS1hPalhrZHZuY3U1SkxDSjZ5Y2FnSFprZWlmdGlFaUFncVF2Y2N3SFpmZ1JhNkZvMEJCc1QyRDhtZHp4RlRQdUQ4NFVlclhMXzJsOHJlNG5leUZfbEV3TmVWR3I4a29uMUZxcWJMaDRoTkFyZExpUGZzLXJkRF9NVThzSjRSOUZyakpZTVFWYm9VYmNHTldEeDV5MUM4S1JjS1I?oc=5","date":"2025-08-12","type":"pipeline","source":"Bloomberg.com","summary":"Bayer to Pay $1.3 Billion for Kumquat Cancer Drug in Pharma Push - Bloomberg.com","headline":"Bayer to Pay $1.3 Billion for Kumquat Cancer Drug in Pharma Push","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMirwFBVV95cUxPelBYaUcwYnBQLUxWU3c2TnRRdDhGZVI1NDY5a0xaaXF3bWR2RWRBWVpkYlZaQkRtelBhOEZLdUE0eDNqdFkySmtCT2pkcnFaSGxhNDFPMEpNZkRfVWdwaHlrSTliSng3RmtUS0gwOUJlOFZWX3RraFlPMlJib0t4Sm5DMjZMR1VYR241SXJyTWFCalpqZnNqV2JNVnNPajFiaEVqOUZDa3JZYm1wQm5v?oc=5","date":"2025-08-12","type":"deal","source":"European Biotechnology Magazine","summary":"Bayer announces US$1.3bn oncology deal with Kumquat Biosciences - European Biotechnology Magazine","headline":"Bayer announces US$1.3bn oncology deal with Kumquat Biosciences","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiqAFBVV95cUxNREM5NFVNU0VTSHMwRHMtdlk4eld6SGVNaXY5TEg3ZFE1TlI5RDBaX0VIdU9zRGxFczVIUTBJcWxCdnJNMVd0WUV4LVB2LWp4alBuLW1BcTRTenJpX1JweGIzanJQc21xSEFFR2tVc3hwcGRTeTk4TGVDNTlrYTZsdGd6TDZydHJuOXJvdHhfWWsxd0Z0MHZ5bkp5U1pQOW4zemxCOWtqNjY?oc=5","date":"2025-08-12","type":"pipeline","source":"WSJ","summary":"Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug - WSJ","headline":"Bayer, Kumquat Biosciences Team Up on New Potential Cancer Drug","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxNQ3ZIT3V5T3pwOWZpdk5Mc2trbDAwYTd5dmh5SHJDQ2hwYUdGWGtWTmsycmE3TVN5cTdHR01zZi1jaHZiRy1tUlJ5b0p5SUhIRHVFaDNpdThFU0NpSE1CUmtialIwa18yQURLVHpkUzAwSGxQTUkwU0VoMXNxSFpyRlBfamppUl9TNmFpeEZZYjZET1pkM1ZzVGMzU3Q?oc=5","date":"2025-08-12","type":"deal","source":"BioWorld News","summary":"Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal - BioWorld News","headline":"Bayer secures KRAS G12D inhibitor with $1.3B Kumquat deal","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinAFBVV95cUxPb2tlcFlUUl81QzNDZjg2T29qT00xZ1MtNkVDU0xJY2tBVVRtNFlMeXlBaHU1OVg2NlFMN1hlVTJLbXpobXdUeHVPdEN5N2Q5VHhQdU5EM2JhNEhuaWg0VnVqM2FEZUo0b3B5a2ZheXNkd3AxRk5lWGZ0UEhXNE11dzhjUDNwZklEVFh2Y05iSDNhWUNLVlFkdjRzWTM?oc=5","date":"2024-04-16","type":"deal","source":"Fierce Biotech","summary":"Takeda inks sweet $1.2B-plus deal with Kumquat for immuno-oncology program - Fierce Biotech","headline":"Takeda inks sweet $1.2B-plus deal with Kumquat for immuno-oncology program","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_2":1},"enrichmentLevel":2,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}